Subcutaneous Risankizumab Induction Improved Outcomes in Crohn’s Disease

Subcutaneous Risankizumab Induction Improved Outcomes in Crohn’s Disease

octobre 16, 2026

You don’t have permission to access « http://www.medpagetoday.com/meetingcoverage/acg/123451 » on this server.

Reference #18.3bf2da17.1792176307.2164301e

https://errors.edgesuite.net/18.3bf2da17.1792176307.2164301e

Read More

fr_FRFrench